HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Local injection of bleomycin A5 in lymphangioma in children. Analysis of 100 cases].

Abstract
From Jan. 1985 to Dec. 1988, 100 newborn and small infants suffering from lymphangioma were treated with bleomycin A5 injecting into lymphangioma. The cases were divided into three types: (1) Bleomycin A5 local injection into the lymphangioma were practiced on 70 cases; (2) Surgical partial resection of lymphangioma plus local injection on 26 cases; (3) A previous excision but recurred postoperatively were 4 cases. The dosage of bleomycin A5 was 10 mg per time. The therapeutic course was not more than 5 times. The efficacy of bleomycin A5 were satisfactory in all cases except only one case with a large lymphangioma of previous palliative excision but recurred. There was not a recurrent patient at following-up from 3 months to 4 years.
AuthorsJ P Jiang
JournalZhonghua wai ke za zhi [Chinese journal of surgery] (Zhonghua Wai Ke Za Zhi) Vol. 27 Issue 12 Pg. 741-2, 781 (Dec 1989) ISSN: 0529-5815 [Print] China
PMID2483986 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Bleomycin
  • bleomycetin
Topics
  • Antibiotics, Antineoplastic (administration & dosage, therapeutic use)
  • Bleomycin (administration & dosage, therapeutic use)
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Female
  • Head and Neck Neoplasms (drug therapy)
  • Humans
  • Infant
  • Infant, Newborn
  • Injections, Intralesional
  • Lymphangioma (drug therapy)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: